Publications by authors named "Hitoshi Tatebe"

Claim this Profile
L
Long-term outcomes of concurrent chemo-proton therapy for unresectable stage III non-small cell lung cancer: a Japanese national registry study.
Hiromitsu Iwata, Masao Murakami, Kazushi Maruo, Masaki Nakamura, Takahiro Waki, Hitoshi Tatebe

Radiother Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of proton beam therapy for inoperable stage I-IIA non-small cell lung cancer: Japanese nationwide registry study.
Masaki Nakamura, Kazushi Maruo, Masao Murakami, Takashi Ogino, Hiromitsu Iwata, Hitoshi Tatebe

Radiother Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory-gated proton beam therapy for intrahepatic cholangiocarcinoma without fiducial markers.
Akihito Okubo, Sae Matsumoto, Hiroyasu Tamamura, Yoshitaka Sato, Satoko Asahi, Hitoshi Tatebe

Radiat Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proton and carbon ion radiotherapy for operable early-stage lung cancer; a prospective nationwide registry.
Hideyuki Harada, Hiroaki Suefuji, Keita Mori, Hitoshi Ishikawa, Masaki Nakamura, Hitoshi Tatebe

Radiother Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive analysis of Japanese nationwide cohort data of particle beam therapy for pulmonary, liver and lymph node oligometastases: particle beam therapy versus high-precision X-ray radiotherapy.
Norihiro Aibe, Hiroyuki Ogino, Masaru Wakatsuki, Kei Fujikawa, Satoshi Teramukai, Hitoshi Tatebe

J Radiat Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of CT-image guidance in proton therapy for liver cancer and the importance of daily dose monitoring for tumors and organs at risk.
Yoshikazu Maeda, Keiji Kobashi, Yoshitaka Sato, Hiroyasu Tamamura, Kazutaka Yamamoto, Hitoshi Tatebe

Med Phys· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical results of proton beam radiotherapy for inoperable stage III non-small cell lung cancer: a Japanese national registry study.
Hitoshi Tatebe, Hideyuki Harada, Keita Mori, Hiromitsu Iwata, Tetsuo Akimoto

J Radiat Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Exposure Doses of Elective Nodal Irradiation in Chemoradiotherapy for Advanced Esophageal Cancer.
Hiroyasu Tamamura, Kenkei Hasatani, Sae Matsumoto, Satoko Asahi, Hitoshi Tatebe

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Results of Proton Therapy for Hepatocellular Carcinoma Using Four-Dimensional Computed Tomography Planning without Fiducial Markers.
Sayuri Bou, Shigeyuki Takamatsu, Sae Matsumoto, Satoko Asahi, Hitoshi Tatebe

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-institutional feasibility study of intensity-modulated radiotherapy with chemotherapy for locally advanced non-small cell lung cancer.
Hideyuki Harada, Shota Omori, Keita Mori, Masahiro Konno, Haruyasu Murakami, Hitoshi Tatebe

Int J Clin Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Rapamycin on the Radio-Sensitivity of Cultured Tumor Cells Following Boron Neutron Capture Reaction.
Hitoshi Tatebe, Shin-Ichiro Masunaga, Yasumasa Nishimura

World J Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil-to-Lymphocyte Ratio Predicts Survival After Whole-brain Radiotherapy in Non-small Cell Lung Cancer.
Hiroshi Doi, Kiyoshi Nakamatsu, Shimpei Anami, Kohei Fukuda, Masahiro Inada, Hitoshi Tatebe

In Vivo· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Hypoxia Detected by F-fluoromisonidazole Positron Emission Tomography (FMISO PET) as a Prognostic Indicator of Radiotherapy (RT).
Izumi Tachibana, Yasumasa Nishimura, Kohei Hanaoka, Masahiro Inada, Kohei Fukuda, Hitoshi Tatebe

Anticancer Res· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-step Intensity-modulated Radiation Therapy for Oropharyngeal Cancer: Initial Clinical Experience and Validation of Clinical Staging.
Hitoshi Tatebe, Hiroshi Doi, Kazuki Ishikawa, Hisato Kawakami, Masaki Yokokawa

Anticancer Res· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of oxygen pressure during incubation with a (10)B-carrier on (10)B uptake capacity of cultured p53 wild-type and mutated tumor cells: dependency on p53 status of tumor cells and types of (10)B-carriers.
Shin-ichiro Masunaga, Hitoshi Tatebe, Yasumasa Nishimura, Keizo Tano, Yu Sanada

Int J Radiat Biol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple primary malignancies in patients with prostate cancer: increased risk of secondary malignancies after radiotherapy.
Kaoru Okajima, Kazuki Ishikawa, Tomohiro Matsuura, Hitoshi Tatebe, Kazuhisa Fujiwara

Int J Clin Oncol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis